Procter & Gamble Hygiene and Health Care Ltd. has announced its financial results for the quarter ended December 31, 2022. In a challenging cost and operating environment, the Company continued to make sequential progress in the quarter and delivered sales of ?1137 crores, up 4% vs year ago behind its trusted product portfolio and superior retail execution. The Company delivered growth despite a pandemic driven high demand on the healthcare portfolio in the base period.
Profit After Tax (PAT) was ?207 crores, down 2% vs year ago largely behind commodity cost inflation. Compared to the corresponding pre-covid quarter three years ago, company sales are up 32% and PAT is up 53%. The company continues to maintain market share leadership across both Feminine Hygiene and Healthcare categories.
LV Vaidyanathan, Managing Director, Procter & Gamble Hygiene and Health Care Ltd. shared, "Despite external headwinds and macro-economic environment, we delivered a resilient performance as this quarter recorded sequential progress across topline and bottom line, enabled by the strength of our brands and executional excellence. This has been possible behind our integrated growth strategies of a focused product portfolio, superiority, productivity, constructive disruption, and an agile and accountable organization. We believe that these are the right strategies for us to navigate the nearterm challenges and drive a balanced growth."
The Board of Directors declared an interim dividend of ? 80 on every equity share of ?10. The record date for the dividend will be February 8, 2023.
Shares of Procter & Gamble Hygiene and Health Care Limited was last trading in BSE at Rs. 14160.80 as compared to the previous close of Rs. 13756.20. The total number of shares traded during the day was 404 in over 245 trades.
The stock hit an intraday high of Rs. 14349.00 and intraday low of 13578.95. The net turnover during the day was Rs. 5629583.00.